Eastman Completes $2.8 Billion Takeover of Taminco

US chemical producer Eastman has completed its acquisition of compatriot Taminco for $2.8 billion in cash and assumed debt of an estimated $1 billion.

Eastman said the acquired assets should be accretive to earnings in 2015.

Stockholders of Taminco, a major producer of alklylamines and alkylamine derivatives, will receive $26 in cash for each of their Taminco common shares. The stock has been delisted from trading on the New York Stock Exchange.

Taminco's Specialty Amines and Crop Protection businesses will be operated as part of Eastman's Additives & Functional Products segment. Its Functional Amines business will be operated as part of the Tennessee-based chemical company's Specialty Fluids & Intermediates segment.

Mark Costa, Eastman's chairman and CEO, said: "Taminco's world-class alkylamine technology platform and strong presence in attractive niche end markets will further strengthen our position as a leading specialty chemical company." He added that Eastman is "committed to successful integration of Taminco and looks forward to delivering the projected synergies of this transaction."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.